Sign in to view content

Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration

Justis P. Ehlers, MD, FASRS

Video
Published 2020

Related

Episode 138: Journal Club Including DRIL in RVO, Sickle Cell Retinopathy Characteristics, and Scleral Depression for PVDs
Jayanth Sridhar, MD
Member Podcasts
2018
Mitochondria-Targeted Drug Elamipretide for Treatment of Vision Loss in Dry AMD With Noncentral Geographic Atrophy
Scott W. Cousins, MD
Annual Meeting Talks
2019
Classification and Guidelines for Widefield Imaging: Recommendations From the International Widefield Imaging Study Group
Netan Choudhry, MD, FRCS(C) FASRS
Updates from the Field
2019

Category: AMD-Non-Neovascular

See more